table of content
1 Introduction to Research & Analysis Reports
1.1 Non-alcoholic Steatohepatitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-alcoholic Steatohepatitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-alcoholic Steatohepatitis Overall Market Size
2.1 Global Non-alcoholic Steatohepatitis Market Size: 2023 VS 2030
2.2 Global Non-alcoholic Steatohepatitis Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-alcoholic Steatohepatitis Players in Global Market
3.2 Top Global Non-alcoholic Steatohepatitis Companies Ranked by Revenue
3.3 Global Non-alcoholic Steatohepatitis Revenue by Companies
3.4 Top 3 and Top 5 Non-alcoholic Steatohepatitis Companies in Global Market, by Revenue in 2023
3.5 Global Companies Non-alcoholic Steatohepatitis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-alcoholic Steatohepatitis Players in Global Market
3.6.1 List of Global Tier 1 Non-alcoholic Steatohepatitis Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-alcoholic Steatohepatitis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-alcoholic Steatohepatitis Market Size Markets, 2023 & 2030
4.1.2 Solid
4.1.3 Liquid
4.2 By Type - Global Non-alcoholic Steatohepatitis Revenue & Forecasts
4.2.1 By Type - Global Non-alcoholic Steatohepatitis Revenue, 2019-2024
4.2.2 By Type - Global Non-alcoholic Steatohepatitis Revenue, 2025-2030
4.2.3 By Type - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-alcoholic Steatohepatitis Market Size, 2023 & 2030
5.1.2 Oral
5.1.3 Parenteral
5.2 By Application - Global Non-alcoholic Steatohepatitis Revenue & Forecasts
5.2.1 By Application - Global Non-alcoholic Steatohepatitis Revenue, 2019-2024
5.2.2 By Application - Global Non-alcoholic Steatohepatitis Revenue, 2025-2030
5.2.3 By Application - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Non-alcoholic Steatohepatitis Market Size, 2023 & 2030
6.2 By Region - Global Non-alcoholic Steatohepatitis Revenue & Forecasts
6.2.1 By Region - Global Non-alcoholic Steatohepatitis Revenue, 2019-2024
6.2.2 By Region - Global Non-alcoholic Steatohepatitis Revenue, 2025-2030
6.2.3 By Region - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Non-alcoholic Steatohepatitis Revenue, 2019-2030
6.3.2 US Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.3.3 Canada Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.3.4 Mexico Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Non-alcoholic Steatohepatitis Revenue, 2019-2030
6.4.2 Germany Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4.3 France Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4.4 U.K. Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4.5 Italy Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4.6 Russia Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4.7 Nordic Countries Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.4.8 Benelux Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Non-alcoholic Steatohepatitis Revenue, 2019-2030
6.5.2 China Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.5.3 Japan Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.5.4 South Korea Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.5.5 Southeast Asia Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.5.6 India Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Non-alcoholic Steatohepatitis Revenue, 2019-2030
6.6.2 Brazil Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.6.3 Argentina Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-alcoholic Steatohepatitis Revenue, 2019-2030
6.7.2 Turkey Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.7.3 Israel Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.7.4 Saudi Arabia Non-alcoholic Steatohepatitis Market Size, 2019-2030
6.7.5 UAE Non-alcoholic Steatohepatitis Market Size, 2019-2030
7 Non-alcoholic Steatohepatitis Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Non-alcoholic Steatohepatitis Major Product Offerings
7.1.4 AstraZeneca Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Non-alcoholic Steatohepatitis Major Product Offerings
7.2.4 Pfizer Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.2.5 Pfizer Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Non-alcoholic Steatohepatitis Major Product Offerings
7.3.4 GSK Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.3.5 GSK Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Major Product Offerings
7.4.4 Novo Nordisk Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Non-alcoholic Steatohepatitis Major Product Offerings
7.5.4 Roche Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.5.5 Roche Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Non-alcoholic Steatohepatitis Major Product Offerings
7.6.4 AbbVie Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.6.5 AbbVie Key News & Latest Developments
7.7 Galectin Therapeutics
7.7.1 Galectin Therapeutics Company Summary
7.7.2 Galectin Therapeutics Business Overview
7.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Major Product Offerings
7.7.4 Galectin Therapeutics Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.7.5 Galectin Therapeutics Key News & Latest Developments
7.8 Galmed Pharmaceuticals
7.8.1 Galmed Pharmaceuticals Company Summary
7.8.2 Galmed Pharmaceuticals Business Overview
7.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Major Product Offerings
7.8.4 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.8.5 Galmed Pharmaceuticals Key News & Latest Developments
7.9 Gilead
7.9.1 Gilead Company Summary
7.9.2 Gilead Business Overview
7.9.3 Gilead Non-alcoholic Steatohepatitis Major Product Offerings
7.9.4 Gilead Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.9.5 Gilead Key News & Latest Developments
7.10 Intercept pharma
7.10.1 Intercept pharma Company Summary
7.10.2 Intercept pharma Business Overview
7.10.3 Intercept pharma Non-alcoholic Steatohepatitis Major Product Offerings
7.10.4 Intercept pharma Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.10.5 Intercept pharma Key News & Latest Developments
7.11 Non-alcoholic Steatohepatitis
7.11.1 Non-alcoholic Steatohepatitis Company Summary
7.11.2 Non-alcoholic Steatohepatitis Business Overview
7.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Major Product Offerings
7.11.4 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.11.5 Non-alcoholic Steatohepatitis Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Non-alcoholic Steatohepatitis Major Product Offerings
7.12.4 Takeda Non-alcoholic Steatohepatitis Revenue in Global Market (2019-2024)
7.12.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
